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During the last 50 years the subspeciality of clinical infectious
diseases has evolved in a number of European countries. The
clinical infectious disease physician is now accepted as an
established specialist, as is the medical microbiologist. This
paper describes the current situation and outlines proposals of
a model for the future arrangements for the management of
infection.
There is considerable variation in the way patients with
infectious diseases are cared for in Europe. In a number of
countries, including the Netherlands, the model of care has
changed considerably over the years. An early model, still
encountered in some centres, is that in which the medical
microbiologist is con¢ned to the laboratory, while clinicians
take care of patients; there is minimal interaction and consul-
tation between the microbiologist and the clinicians. A
slightly more developed model provides some consultation, as
diagnostic laboratory ¢ndings as well as therapeutic advice is
conveyed by note or telephone. A further development is one
where the medical microbiologist provides bedside advice
about diagnostic procedures and treatment to clinicians; this
model is quite prevalent in many of the community hospitals
in theNetherlands.
A quite di¡erent model is the one inwhich the microbiolo-
gist runs the laboratory and the infectious disease specialist
gives advice to clinicians. This particular model is unsatisfac-
tory and can lead to professional con£icts. A better model is
that of the medical microbiologist, whilst still running the
laboratory, providing bedside advice, and interacting with the
infectious disease specialist and other clinicians. In recent
years, a number of university hospitals in the Netherlands
(especially those in Rotterdam, Utrecht and Nijmegen) have
developed this model to create one in which there is strong
collaboration between the infectious disease specialist, the
medical microbiologist and the hospital infection control ser-
vice. The hospital pharmacist may further complement this
service. Together these specialists create what Dr LTompkins
has called `the infectious disease service line'. The establish-
ment of similar infectious disease teams of joint expertise of
microbiologists and clinicians was proposed by a working
party of the Royal College of Physicians and the Royal Col-
lege of Pathologists in the United Kingdom in 1990 [1]. Such
joint expertise should not be restricted to the hospital environ-
ment, but should extend outside the hospital so that there is
collaboration between the infectious disease specialist, the
medical microbiologist, general practioners (especially with
regard to antibiotic treatment), public health physicians and
health authorities. This creates a powerful model for dealing
with themanychallenges of infectious diseases.
For the infectious disease clinician, the challenge still
remains at the bedside. The diagnostic challenge is whether
there is an infection or whether signs and symptoms can be
otherwise explained. The di¡erential diagnosis may range
from neoplasia to artefact. Should an infection be considered
most likely, the etiology may range from helminth to prion.
This area of expertise for the infectious disease physician is an
important and unique skill that is not part of the training or
expertise of most microbiologists.
In addition to the diagnostic challenges are the therapeutic
challenges. A large proportion of consultative advice concerns
suboptimal antimicrobial treatment; inappropriate choice of
antibiotic (often the spectrum being too wide), inadequate
dosage, inappropriate duration or route of administration, as
well as potentially toxic treatment [2, 3]. To advise or pre-
scribe, taking all aspects of a patient's condition into consid-
eration, is a major area of expertise of the infectious disease
physician and includes not only antimicrobial therapy, but also
supportive treatment, which may include nutritional support
to immunoglobulin therapy. Although evidence-based pre-
scribing is currently emphasized, in many instances robust
evidence is lacking. In these cases prescribing of both antimi-
crobial and supportive therapy becomes an important art that
must be acquired.
A further challenge for the infectious disease physician con-
cerns the prevention of infection. Implementation of good
hospital hygiene practice is an area that must not be neglected
by the infectious disease physician, who should be an example
for other physicians and healthcare workers, particularly with
hand hygiene.The same holds true for compliance with isola-
tion procedures; even including simple measures such as wear-
ing a clean white coat and not sitting on hospital beds. The
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infectious disease physician should not be afraid to correct
and educate other healthcareworkers.
Another important area of expertise is the prevention of
infectious disease. The infectious disease physician should be
an expert in vaccination policies, and be able to give advice to
patients as well as travel advice to the public.The need for such
expertise will increase as new vaccines are developed. Allied
to the prevention of infection is knowledge in the use of anti-
biotic prophylaxis. Concerns about misuse are an important
area of concern.This is particularly the case with surgical pro-
phylaxis (e.g. wrong timing, wrong drugs, too many dosages)
[4, >5], but also extends to controversial areas of application
such as selective decontamination of the digestive tract in
intensive care patients.
The new challenges for the infectious disease specialist are
manifold. First of all, there are the emerging and re-emerging
pathogens. In addition, there is the global increase in antimi-
crobial resistance, which is occurring in the face of a dearth in
the development of new antibacterial drugs. Thus, many of
the emerging pathogens must be treatedwith established anti-
microbial drugs.This will only remain possible if the standard
of prescribing and compliancewith hospital hygiene improves
[6]. At the same time there is a revolution happening in diag-
nostic medical microbiology, with rapid and often molecular-
based tests appearing.The clinical application of many of these
new tests is unclear at the moment, yet there will need to be
profound changes in the ordering of tests and also in turn the
way clinical decision-making is conducted. The infectious
disease specialist should be involved in the critical evaluation
of these new tests, as there is a danger that inexperienced phy-
sicians will rely more heavily on the results of such tests and
less on clinical judgement. The increasing number of patients
with severe host defence defects poses a particular challenge.
There is an urgent need for new techniques to assess the state
of host defences.This is particularly so with the advent of the
new immunotherapeutic management of infection.
What should the pro¢le of the infectious disease specialist
be? First of all, he or she should be clinically well trained in
internal medicine or in pediatrics. Subspeciality training
should encompass clinical infectious diseases, practical skills in
diagnostic medical microbiology, training in epidemiology,
public health and hygiene, and also research training.Tropical
infectious diseases should also be included in the training pro-
gram.Muchweight should be given to the etiology, pathogen-
esis, diagnosis, and management of infectious diseases. The
trainee should be fully conversant with the therapeutic aspect
of disease management including the pharmacology of anti-
microbial drugs, antibiotic policies, prescribing, and suppor-
tive care. Likewise, approaches to prevention (hygiene and
vaccination strategies) should be fullymastered.
Such training programs are very demanding. The total
duration of medical training, i.e. medical studies, speciality
training and subspeciality training is particularly long in the
Netherlands. The issue of whether training programs should
be shortened is currently under discussion. In some countries
(e.g. the United States), developments are taking place which
create serious threats for the infectious disease service. One
such concern is that in theUSA the medically quali¢ed micro-
biologist is extremely rare; most laboratories are run by
science graduates.
The development of commercial diagnostic microbiology
laboratories located at a distance from the hospital raises
further concerns. Both developments interfere with the fun-
damental concept of the `infectious disease service line' and
present new challenges to the quality of care for the patient
with infectious disease. It is important that all such challenges
are addressed in a rapidly changingworld.
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